---
title: "15 年前投資$1000 於 Verisk Analytics，今天的價值會是多少"
description: "Verisk Analytics（VRSK）在過去 15 年中年化超越市場 3.22%，平均年回報率為 15.64%。目前，Verisk Analytics 的市值為 345.8 億美元"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/258129068.md"
published_at: "2025-09-19T16:06:47.000Z"
---

# 15 年前投資$1000 於 Verisk Analytics，今天的價值會是多少

> Verisk Analytics（VRSK）在過去 15 年中年化超越市場 3.22%，平均年回報率為 15.64%。目前，Verisk Analytics 的市值為 345.8 億美元

Verisk Analytics VRSK has outperformed the market over the past 15 years by 3.22% on an annualized basis producing an average annual return of 15.64%. Currently, Verisk Analytics has a market capitalization of $34.58 billion.

### Related Stocks

- [VRSK.US - Verisk Analytics](https://longbridge.com/zh-HK/quote/VRSK.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Verisk Analytics Names Steven Kauderer President of Claims Solutions | Verisk Analytics Inc. has appointed Steven Kauderer as president of its Claims Solutions business, reporting to CEO Lee  | [Link](https://longbridge.com/zh-HK/news/275324750.md) |
| BI Asset Management Fondsmaeglerselskab A S Has $8.35 Million Position in Verisk Analytics, Inc. $VRSK | BI Asset Management Fondsmaeglerselskab A S increased its stake in Verisk Analytics, Inc. by 159.8% in Q3, owning 33,189 | [Link](https://longbridge.com/zh-HK/news/275112118.md) |
| Verisk Analytics' Q4 2025 Earnings: What to Expect | Verisk Analytics' Q4 2025 Earnings: What to Expect | [Link](https://longbridge.com/zh-HK/news/273225804.md) |
| TD Private Client Wealth LLC Sells 6,970 Shares of Verisk Analytics, Inc. $VRSK | TD Private Client Wealth LLC reduced its stake in Verisk Analytics, Inc. (NASDAQ:VRSK) by 57.8% in Q3, selling 6,970 sha | [Link](https://longbridge.com/zh-HK/news/272690142.md) |
| Verisk Analytics (VRSK) Receives a Buy from RBC Capital | RBC Capital analyst Ashish Sabadra has maintained a Buy rating on Verisk Analytics (VRSK) with a price target of $250.00 | [Link](https://longbridge.com/zh-HK/news/271589304.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。